# Vitalant – FDA Inspection, Feb 23, 2023

Source: https://www.keypedia.com/records/fda_inspections/vitalant/70bbf3d4-9efe-4ef4-8762-ae5c6f64d512
Source feed: FDA_Inspections

> FDA inspection 1199227 of Vitalant, February 23, 2023. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1199227
- Company Name: Vitalant
- Inspection Date: 2023-02-23
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1098666 - 2019-07-18
- FDA Inspection 1013136 - 2017-05-12
- FDA Inspection 926675 - 2015-04-23
- FDA Inspection 815149 - 2013-01-16
- FDA Inspection 710393 - 2011-02-14

## Related Officers

- [Emily S. McGann](https://www.keypedia.com/people/emily-s-mcgann/43891ff3-bd70-4337-b61c-e16cc7ad0468)
- [FDA Associated Person](https://www.keypedia.com/people/gloria-a-milster/22f95276-6f68-467d-8d52-5c028c118123)

Company: https://www.keypedia.com/companies/vitalant/819be064-b04c-415c-88c3-3a478a9182b5

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d